Genomma Lab’s $510 Million Medium Terms Notes Program

DLA Piper advised on the authorization process

Genomma Lab secured the authorization from the Mexican National Baking and Stock Commission CNBV $510 Million Medium Terms Notes Program.

Genomma Lab Internacional SAB de CV develops, markets, sells and distributes over-the-counter drugs and personal care products. The company, led by Jorge Luis Brake Valderrama, Antonio Zamora Galland and Marco Sparvieri, in 2018 recorded $602 million revenues.

DLA Piper advised Genomma Lab Internacional S.A.B. de C.V. with a team including Xavier Mangino Dueñas (Picture) and Cristian Gastelum.

Involved fees earner: Cristian Gastelum – DLA Piper; Xavier Mangino – DLA Piper;

Law Firms: DLA Piper;

Clients: Genomma Lab Internacional SAB de CV;

Author: Ambrogio Visconti.